Skip to main content
TITAN PHARMACEUTICALS INC logo

TITAN PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · TTNP ISIN · US8883146065 LEI · 549300NOUZGB2ZNVJ794 US Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2010-05-14 Interim / Quarterly Rep…
Country US United States of America
Listing US TTNP

About TITAN PHARMACEUTICALS INC

https://www.titanpharm.com/

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q1 2010
2010-05-14 English
Regulatory Filings 2010
Regulatory Filings
2010-05-12 English
FILED PURSUANT TO RULE 424(B)(3)
Capital/Financing Update Classification · 95% confidence The document is a Form 424B3 prospectus filed pursuant to Rule 424(b)(3) related to the resale of common stock by selling stockholders. It includes detailed information about the offering, risk factors, use of proceeds, company description, management discussion, and consolidated financial statements. The document is a registration/prospectus filing related to capital raising and share resale, not a financial report, earnings release, or management discussion report. It is not an announcement of a report but the actual prospectus document. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to a securities offering and capital raising activity.
2010-05-11 English
Capital/Financing Update 2010
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the Securities and Exchange Commission requesting acceleration of the effective date for a Registration Statement on Form S-1. This is related to the process of registering securities for public offering, which is a capital raising activity. The document is short (1430 characters) and is a formal request rather than a report or financial statement. It does not contain financial data or results, nor is it a report publication announcement. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2010-05-07 English
AMENDMENT NO. 1 TO FORM S-1
Regulatory Filings Classification · 95% confidence The document is titled 'Amendment No. 1 to Form S-1 Registration Statement' filed with the SEC, which is a registration statement under the Securities Act of 1933. It includes detailed information about the company, securities being registered, risk factors, use of proceeds, management discussion and analysis, financial data, and other disclosures typical of a registration statement for securities offering. This is not an earnings release, annual report, or other financial report but a regulatory filing related to securities registration. Form S-1 and its amendments are used for initial public offerings or other securities registrations and fall under the category of Regulatory Filings (RNS) in the provided classification scheme, as there is no specific category for registration statements or prospectuses. The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or certification, so it is not RPA or a certification. Therefore, the best fitting classification is Regulatory Filings (RNS).
2010-05-05 English
Regulatory Filings 2010
Regulatory Filings
2010-05-04 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.